This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

18 Apr 2011

Merrimack Raises $77M to Develop Cancer Drug

Merrimack Pharmaceuticals Inc., a company developing cancer drugs, said it has raised $77 million in a private financing round.

Cambridge-based biotech Merrimack has raised $77 million for the development of its cancer drug pipeline. Investors in the Series G round include Credit Suisse First Boston Next Fund, Crocker Ventures, funds advised by Fred Alger Management,  funds advised by Noonday Asset Management, Jennison Associates, TPG-Axon Capital and WT Investment Advisors Fund.


Related News